PubMed:32149769 / 260-445 JSONTXT

{"project":"LitCovid-OGER-BB","denotations":[{"id":"T8","span":{"begin":9,"end":13},"obj":"CHEBI:23888"},{"id":"T9","span":{"begin":9,"end":13},"obj":"CHEBI:23888"},{"id":"T10","span":{"begin":35,"end":44},"obj":"SP_7"},{"id":"T11","span":{"begin":150,"end":183},"obj":"SP_7"}],"namespaces":[{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"}],"text":"However, drug screening using live 2019-nCoV requires high-level biosafety facilities, which imposes an obstacle for those without such facilities or 2019-novel coronavirus (2019-nCoV)."}

{"project":"LitCovid-PAS-Enju","denotations":[{"id":"EnjuParser_T37","span":{"begin":0,"end":7},"obj":"RB"},{"id":"EnjuParser_T38","span":{"begin":7,"end":8},"obj":"-COMMA-"},{"id":"EnjuParser_T39","span":{"begin":9,"end":13},"obj":"NN"},{"id":"EnjuParser_T40","span":{"begin":14,"end":23},"obj":"NN"},{"id":"EnjuParser_T41","span":{"begin":24,"end":29},"obj":"VBG"},{"id":"EnjuParser_T42","span":{"begin":30,"end":34},"obj":"JJ"},{"id":"EnjuParser_T43","span":{"begin":35,"end":44},"obj":"NN"},{"id":"EnjuParser_T44","span":{"begin":45,"end":53},"obj":"VBZ"},{"id":"EnjuParser_T45","span":{"begin":54,"end":64},"obj":"JJ"},{"id":"EnjuParser_T46","span":{"begin":65,"end":74},"obj":"NN"},{"id":"EnjuParser_T47","span":{"begin":75,"end":85},"obj":"NNS"},{"id":"EnjuParser_T48","span":{"begin":85,"end":86},"obj":"-COMMA-"},{"id":"EnjuParser_T49","span":{"begin":87,"end":92},"obj":"WDT"},{"id":"EnjuParser_T50","span":{"begin":93,"end":100},"obj":"VBZ"},{"id":"EnjuParser_T51","span":{"begin":101,"end":103},"obj":"DT"},{"id":"EnjuParser_T52","span":{"begin":104,"end":112},"obj":"NN"},{"id":"EnjuParser_T53","span":{"begin":113,"end":116},"obj":"IN"},{"id":"EnjuParser_T54","span":{"begin":117,"end":122},"obj":"DT"},{"id":"EnjuParser_T55","span":{"begin":123,"end":130},"obj":"IN"},{"id":"EnjuParser_T56","span":{"begin":131,"end":135},"obj":"JJ"},{"id":"EnjuParser_T57","span":{"begin":136,"end":146},"obj":"NNS"},{"id":"EnjuParser_T58","span":{"begin":147,"end":149},"obj":"CC"},{"id":"EnjuParser_T59","span":{"begin":150,"end":160},"obj":"JJ"},{"id":"EnjuParser_T60","span":{"begin":161,"end":172},"obj":"NN"},{"id":"EnjuParser_T61","span":{"begin":173,"end":174},"obj":"-LRB-"},{"id":"EnjuParser_T62","span":{"begin":174,"end":183},"obj":"NN"},{"id":"EnjuParser_T63","span":{"begin":183,"end":184},"obj":"-RRB-"}],"relations":[{"id":"EnjuParser_R35","pred":"arg1Of","subj":"EnjuParser_T44","obj":"EnjuParser_T37"},{"id":"EnjuParser_R36","pred":"arg1Of","subj":"EnjuParser_T44","obj":"EnjuParser_T38"},{"id":"EnjuParser_R37","pred":"arg1Of","subj":"EnjuParser_T40","obj":"EnjuParser_T39"},{"id":"EnjuParser_R38","pred":"arg1Of","subj":"EnjuParser_T40","obj":"EnjuParser_T41"},{"id":"EnjuParser_R39","pred":"arg2Of","subj":"EnjuParser_T43","obj":"EnjuParser_T41"},{"id":"EnjuParser_R40","pred":"arg1Of","subj":"EnjuParser_T43","obj":"EnjuParser_T42"},{"id":"EnjuParser_R41","pred":"arg1Of","subj":"EnjuParser_T40","obj":"EnjuParser_T44"},{"id":"EnjuParser_R42","pred":"arg2Of","subj":"EnjuParser_T47","obj":"EnjuParser_T44"},{"id":"EnjuParser_R43","pred":"arg1Of","subj":"EnjuParser_T47","obj":"EnjuParser_T45"},{"id":"EnjuParser_R44","pred":"arg1Of","subj":"EnjuParser_T47","obj":"EnjuParser_T46"},{"id":"EnjuParser_R45","pred":"arg1Of","subj":"EnjuParser_T47","obj":"EnjuParser_T48"},{"id":"EnjuParser_R46","pred":"arg1Of","subj":"EnjuParser_T47","obj":"EnjuParser_T49"},{"id":"EnjuParser_R47","pred":"arg1Of","subj":"EnjuParser_T47","obj":"EnjuParser_T50"},{"id":"EnjuParser_R48","pred":"arg2Of","subj":"EnjuParser_T52","obj":"EnjuParser_T50"},{"id":"EnjuParser_R49","pred":"arg1Of","subj":"EnjuParser_T52","obj":"EnjuParser_T51"},{"id":"EnjuParser_R50","pred":"arg1Of","subj":"EnjuParser_T52","obj":"EnjuParser_T53"},{"id":"EnjuParser_R51","pred":"arg2Of","subj":"EnjuParser_T54","obj":"EnjuParser_T53"},{"id":"EnjuParser_R52","pred":"arg1Of","subj":"EnjuParser_T54","obj":"EnjuParser_T55"},{"id":"EnjuParser_R53","pred":"arg2Of","subj":"EnjuParser_T58","obj":"EnjuParser_T55"},{"id":"EnjuParser_R54","pred":"arg1Of","subj":"EnjuParser_T57","obj":"EnjuParser_T56"},{"id":"EnjuParser_R55","pred":"arg1Of","subj":"EnjuParser_T57","obj":"EnjuParser_T58"},{"id":"EnjuParser_R56","pred":"arg2Of","subj":"EnjuParser_T60","obj":"EnjuParser_T58"},{"id":"EnjuParser_R57","pred":"arg1Of","subj":"EnjuParser_T60","obj":"EnjuParser_T59"},{"id":"EnjuParser_R58","pred":"arg1Of","subj":"EnjuParser_T60","obj":"EnjuParser_T61"},{"id":"EnjuParser_R59","pred":"arg2Of","subj":"EnjuParser_T62","obj":"EnjuParser_T61"},{"id":"EnjuParser_R60","pred":"arg3Of","subj":"EnjuParser_T63","obj":"EnjuParser_T61"}],"text":"However, drug screening using live 2019-nCoV requires high-level biosafety facilities, which imposes an obstacle for those without such facilities or 2019-novel coronavirus (2019-nCoV)."}

{"project":"LitCovid-ArguminSci","denotations":[{"id":"T3","span":{"begin":0,"end":185},"obj":"DRI_Background"}],"text":"However, drug screening using live 2019-nCoV requires high-level biosafety facilities, which imposes an obstacle for those without such facilities or 2019-novel coronavirus (2019-nCoV)."}

{"project":"LitCovid-OGER","denotations":[{"id":"T1","span":{"begin":9,"end":13},"obj":"CHEBI:23888"}],"namespaces":[{"prefix":"PR","uri":"http://purl.obolibrary.org/obo/PR_"},{"prefix":"UBERON","uri":"http://purl.obolibrary.org/obo/UBERON_"}],"text":"However, drug screening using live 2019-nCoV requires high-level biosafety facilities, which imposes an obstacle for those without such facilities or 2019-novel coronavirus (2019-nCoV)."}

{"project":"LitCovid-sentences-v1","denotations":[{"id":"TextSentencer_T4","span":{"begin":0,"end":185},"obj":"Sentence"}],"text":"However, drug screening using live 2019-nCoV requires high-level biosafety facilities, which imposes an obstacle for those without such facilities or 2019-novel coronavirus (2019-nCoV)."}

{"project":"LitCovid-TimeML","denotations":[{"id":"tok48","span":{"begin":0,"end":7},"obj":"RB"},{"id":"tok49","span":{"begin":7,"end":8},"obj":","},{"id":"tok50","span":{"begin":9,"end":13},"obj":"NN"},{"id":"tok51","span":{"begin":14,"end":23},"obj":"NN"},{"id":"tok52","span":{"begin":24,"end":29},"obj":"VBG"},{"id":"tok53","span":{"begin":30,"end":34},"obj":"VB"},{"id":"tok54","span":{"begin":35,"end":39},"obj":"CD"},{"id":"tok55","span":{"begin":39,"end":40},"obj":":"},{"id":"tok56","span":{"begin":40,"end":44},"obj":"NN"},{"id":"tok57","span":{"begin":45,"end":53},"obj":"VBZ"},{"id":"tok58","span":{"begin":54,"end":64},"obj":"JJ"},{"id":"tok59","span":{"begin":65,"end":74},"obj":"NN"},{"id":"tok60","span":{"begin":75,"end":85},"obj":"NNS"},{"id":"tok61","span":{"begin":85,"end":86},"obj":","},{"id":"tok62","span":{"begin":87,"end":92},"obj":"WDT"},{"id":"tok63","span":{"begin":93,"end":100},"obj":"VBZ"},{"id":"tok64","span":{"begin":101,"end":103},"obj":"DT"},{"id":"tok65","span":{"begin":104,"end":112},"obj":"NN"},{"id":"tok66","span":{"begin":113,"end":116},"obj":"IN"},{"id":"tok67","span":{"begin":117,"end":122},"obj":"DT"},{"id":"tok68","span":{"begin":123,"end":130},"obj":"IN"},{"id":"tok69","span":{"begin":131,"end":135},"obj":"JJ"},{"id":"tok70","span":{"begin":136,"end":146},"obj":"NNS"},{"id":"tok71","span":{"begin":147,"end":149},"obj":"CC"},{"id":"tok72","span":{"begin":150,"end":154},"obj":"CD"},{"id":"tok73","span":{"begin":154,"end":155},"obj":":"},{"id":"tok74","span":{"begin":155,"end":160},"obj":"NN"},{"id":"tok75","span":{"begin":161,"end":172},"obj":"JJ"},{"id":"tok76","span":{"begin":173,"end":174},"obj":"("},{"id":"tok77","span":{"begin":174,"end":178},"obj":"CD"},{"id":"tok78","span":{"begin":178,"end":179},"obj":":"},{"id":"tok79","span":{"begin":179,"end":183},"obj":"NN"},{"id":"tok80","span":{"begin":183,"end":184},"obj":")"},{"id":"tok81","span":{"begin":184,"end":185},"obj":"."},{"id":"lookup8","span":{"begin":35,"end":39},"obj":"year"},{"id":"lookup9","span":{"begin":101,"end":103},"obj":"country_code"},{"id":"lookup10","span":{"begin":150,"end":154},"obj":"year"},{"id":"lookup11","span":{"begin":174,"end":178},"obj":"year"},{"id":"event7","span":{"begin":45,"end":53},"obj":"I_STATE"},{"id":"event17","span":{"begin":93,"end":100},"obj":"OCCURRENCE"},{"id":"event23","span":{"begin":24,"end":29},"obj":"OCCURRENCE"}],"text":"However, drug screening using live 2019-nCoV requires high-level biosafety facilities, which imposes an obstacle for those without such facilities or 2019-novel coronavirus (2019-nCoV)."}